Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features
- Kwai Han Yoo
- , Dok Hyun Yoon
- , Hye Jin Kang
- , Won Sik Lee
- , Kihyun Kim
- , Jin Seok Kim
- , Jeong A. Kim
- , Sung Hyun Kim
- , Jae Yong Kwak
- , Yang Soo Kim
- , Chang Ki Min
- , Je Jung Lee
- , Sung Soo Yoon
- , Cheolwon Suh
- , Rachid Baz
- , Jae Hoon Lee*
*Corresponding author for this work
- Gachon University
- University of Ulsan
- Korea Institute of Radiological and Medical Sciences
- Inje University
- Sungkyunkwan University
- Yonsei University
- The Catholic University of Korea
- Dong-A University
- Kosin University
- Chonnam National University
- Seoul National University
- Moffitt Cancer Center
Research output: Contribution to journal › Journal article › peer-review
1
Link opens in a new tab
Scopus
citations